Forskning
Udskriv Udskriv
Switch language
Rigshospitalet - en del af Københavns Universitetshospital
Udgivet

Embryo Morphokinetics and Blastocyst Development After GnRH Agonist versus hCG Triggering in Normo-ovulatory Women: a Secondary Analysis of a Multicenter Randomized Controlled Trial

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

DOI

  1. Human Oocyte Morphology and Outcomes of Infertility Treatment: a Systematic Review

    Publikation: Bidrag til tidsskriftReviewForskningpeer review

  2. DNA Methylation in Ovarian Tumors-a Comparison Between Fresh Tissue and FFPE Samples

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  1. Presence of SARS-CoV-2 in semen and the impact of COVID-19 on the male reproductive system

    Publikation: Bidrag til tidsskriftReviewForskningpeer review

  2. Human Oocyte Morphology and Outcomes of Infertility Treatment: a Systematic Review

    Publikation: Bidrag til tidsskriftReviewForskningpeer review

  3. Assisted reproductive technology treatment and risk of breast cancer: a population-based cohort study

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  4. Calcium transport in male reproduction is possibly influenced by vitamin D and CaSR

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

Vis graf over relationer

Gonadotropin-releasing hormone agonist (GnRHa) for final oocyte maturation, along with vitrification of all usable embryos followed by transfer in a subsequent frozen-thawed cycle, is the most effective strategy to avoid ovarian hyperstimulation syndrome (OHSS). However, less is known about the ovulation induction triggers effect on early embryo development and blastocyst formation. This study is a secondary analysis of a multicenter, randomized controlled trial, with the aim to compare embryo development in normo-ovulatory women, randomized to GnRHa or human chorionic gonadotropin (hCG) trigger. In all, 4056 retrieved oocytes were observed, 1998 from the GnRHa group (216 women) and 2058 from the hCG group (218 women). A number of retrieved oocytes, mature and fertilized oocytes, and high-quality embryos and blastocysts were similar between the groups. A sub-analysis in 250 women enrolled at the main trial site including 2073 oocytes was conducted to compare embryo morphokinetics and cleavage patterns with EmbryoScope time-lapse system. In total, 1013 oocytes were retrieved from the GnRHa group (124 women) and 1060 oocytes were retrieved from the hCG group (126 women). Morphokinetic parameters and cleavage patterns were comparable between the groups. However, embryos derived from the GnRHa group were less likely to perform rolling during their development than the embryos from the hCG trigger group (OR = 0.41 (95%CI 0.25; 0.67), p-value 0.0003). The comparable results on embryo development and utilization rates between the GnRHa and hCG triggers is of clinical relevance to professionals and infertile patients, when GnRHa trigger and freeze-all is performed to avoid OHSS development. ClinicalTrials.gov Identifier: NCT02746562.

OriginalsprogEngelsk
TidsskriftReproductive sciences (Thousand Oaks, Calif.)
Vol/bind28
Udgave nummer10
Sider (fra-til)2972-2981
Antal sider10
ISSN1933-7191
DOI
StatusUdgivet - okt. 2021

Bibliografisk note

Funding Information:
This is a secondary analysis of a multicenter randomized controlled trial, part of the ReproUnion Collaborative study, co-financed by the European Union, Interreg V ÖKS (grant number 20200407). We thank all the participating women and health care professionals for the collaboration.

ID: 64828642